Serum Lactate Dehydrogenase 2 Isoenzyme as Marker of Bone Marrow Infiltration in Non Hodgkin Lymphoma
Keywords:
Non- Hodgkin Lymphoma, mucosa associated lymphoid tissue, Hodgkin Disease, Lactate DehydrogenaseAbstract
Objective: To assess the level of serum lactate dehydrogenase 2 (LD2) in the patients of NHL with and without
bone marrow infiltration.
Introduction: Lactate Dehydrogenase (LDH) is commonly increased in patients with haemopoietic
malignancies and has been shown to be of prognostic value in patients with Non- Hodgkin lymphoma (NHL)
especially. Serum LD2 isoenzyme level was determined in already diagnosed 60 patients of NHL.
Aims and Objectives: Patients were divided into two groups, 30 patients with bone marrow infiltration (group
B) and remaining without infiltration (group C). The values were compared with 20 healthy age and sex matched
contrtols (groupA). The estimations were made prior to the institution of chemotherapy.
Results: LD2 level was significantly raised in NHL patients compared with controls. There was also significant
difference when the values were compared between the patients of NHL with and without bone marrow infiltration.
The levels showed positive correlation with the extent of the disease.
Conclusion: We conclude that the above mentioned non invasive parameter is useful indicator of the extent of
the disease
Downloads
Published
Issue
Section
License
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
